NasdaqGS - Nasdaq Real Time Price USD

Clover Health Investments, Corp. (CLOV)

0.6506 +0.0006 (+0.09%)
As of 9:36 AM EDT. Market Open.
Loading Chart for CLOV
DELL
  • Previous Close 0.6500
  • Open 0.6500
  • Bid 0.6403 x 800
  • Ask 0.6571 x 800
  • Day's Range 0.6466 - 0.6575
  • 52 Week Range 0.6060 - 1.6300
  • Volume 47,236
  • Avg. Volume 9,373,774
  • Market Cap (intraday) 322.237M
  • Beta (5Y Monthly) 1.85
  • PE Ratio (TTM) --
  • EPS (TTM) -0.4400
  • Earnings Date May 7, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 1.44

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.

www.cloverhealth.com/en/

552

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CLOV

Performance Overview: CLOV

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CLOV
31.66%
S&P 500
4.83%

1-Year Return

CLOV
15.51%
S&P 500
20.86%

3-Year Return

CLOV
92.58%
S&P 500
19.61%

5-Year Return

CLOV
--
S&P 500
64.41%

Compare To: CLOV

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CLOV

Valuation Measures

Annual
As of 4/24/2024
  • Market Cap

    321.94M

  • Enterprise Value

    83.92M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.15

  • Price/Book (mrq)

    1.12

  • Enterprise Value/Revenue

    0.04

  • Enterprise Value/EBITDA

    -0.40

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -10.48%

  • Return on Assets (ttm)

    -16.98%

  • Return on Equity (ttm)

    -66.33%

  • Revenue (ttm)

    2.04B

  • Net Income Avi to Common (ttm)

    -213.36M

  • Diluted EPS (ttm)

    -0.4400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    242.68M

  • Total Debt/Equity (mrq)

    1.63%

  • Levered Free Cash Flow (ttm)

    71.6M

Research Analysis: CLOV

Analyst Price Targets

1.00
1.44 Average
0.6506 Current
2.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: CLOV

Fair Value

0.6506 Current
 

Dividend Score

0 Low
CLOV
Sector Avg.
100 High
 

Hiring Score

0 Low
CLOV
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
CLOV
Sector Avg.
100 High
 

People Also Watch